Empyrean Therapeutics Ltd
11372447
Healthy
- No accounts filed in last 18 months (-5)
Details
Compliance
Accounts
Confirmation statement
Industry
Officers
director · Since 21/05/2018
MANAGING DIRECTOR
BRITISH · ENGLAND · Age 44
Also on 2 other boards
Persons with Significant Control
Cambridge Prime Ltd
Building 250 Babraham Research Campus, Cambridge, CB22 3AT
Reg: 12572351 · Cambridge Prime Ltd · Cambridge Prime Ltd
Notified 07/07/2020
Former PSCs
Dr Thomas William Henley
Ceased 22/07/2019
CompanyRankvs 220+ SIC 72110 peers79
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 30/11/2024
Net Worth
£621k
Balance sheet strength
Cash
£304k
Cash in the bank
Net Current Assets
£491k
Working capital
Current Assets
£623k
Current Liabilities
£132k
Fixed Assets
£160k
Debtors
£320k
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2024 | 4.72 | +£81k |
| 2023 | 1.14 | -£497k |
| 2022 | 5.38 | +£170k |
| 2021 | 4.01 | +£120k |
| 2020 | 4.99 | — |
| 2019 | 9.19 | — |
Derived from filed accounts. Not audited figures.